Blood markers in low back pain diagnosis and prognosis
Diagnostic and Prognostic Blood Markers in Non Specific Low Back Pain
This study is testing if certain blood markers can help understand and predict low back pain in people, while also looking at how sleep, depression, anxiety, and physical activity might affect those markers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Islamabad) |
| Trial ID | NCT05751499 on ClinicalTrials.gov |
What this trial studies
This study aims to compare diagnostic and prognostic blood markers in individuals suffering from acute and chronic nonspecific low back pain against healthy controls. It will also explore the relationship between these blood markers and factors such as sleep, depression, and anxiety in affected patients. Additionally, the study will assess how physical activity influences these blood markers in the context of low back pain.
Who should consider this trial
Good fit: Ideal candidates are males and females aged 18-60 diagnosed with nonspecific low back pain in an acute or flared stage.
Not a fit: Patients with serious conditions such as neurological disorders, infections, tumors, or those who have undergone spinal surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and prognostic tools for managing low back pain.
How similar studies have performed: Other studies have shown promise in using blood markers for diagnosing and predicting outcomes in various pain conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Both male \& Female patients 2. Age group 18-60 Years 3. Diagnosed with nonspecific low back pain in acute/flared stage Exclusion Criteria: * Any serious conditions like neurological conditions * Any infection * Tumor * Spinal Surgery * Cognitive Impairments * Refusal to sign consent * patients taking any type of psychological management or rheumatologic disease would be excluded
Where this trial is running
Islamabad
- KRL Hospital — Islamabad, Pakistan (Recruiting)
Study contacts
- Principal investigator: IMRAN AMJAD, PhD — Riphah International University
- Study coordinator: Rana M Tahir, PhD*
- Email: Phyranamuhammadtahir@gmail.com
- Phone: +923333727189
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.